Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma

Thyroid

Volumn 26, Issue 3, 2016, Pages 404-413

  Lee, Doh Young ^a   Won, Jae Kyung ^b   Lee, Se Hoon ^c   Park, Do Joon ^b   Jung, Kyeong Cheon ^b   Sung, Myung Whun ^b   Wu, Hong Gyun ^b   Kim, Kwang Hyun ^b   Park, Young Joo ^b   Hah, J Hun ^b  

^a Korea University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; ANAPLASTIC THYROID CANCER; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; DIFFERENTIATED THYROID CANCER; DISEASE SPECIFIC SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; ADVERSE EFFECTS; AGED; CARCINOMA; CELL DIFFERENTIATION; COMPARATIVE STUDY; EPIDEMIOLOGY; INCIDENCE; LYMPH VESSEL; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SOUTH KOREA; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTOR; TREATMENT OUTCOME; TUMOR INVASION;

ADULT; AGED; CARCINOMA; CELL DIFFERENTIATION; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84962617727     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2015.0316     Document Type: Article

References (40)

1. Tan RK, Finley RK 3rd, Driscoll D, Bakamjian V, Hicks WL Jr, Shedd DP. (1995). Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 17: 41-47; discussion 47-48
2. Spires JR, Schwartz MR, Miller RH. (1988). Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 114: 40-44
3. McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, van Heerden JA, Goellner JR. (2001). Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130: 1028-1034
4. Hunt JL, Tometsko M, LiVolsi VA, Swalsky P, Finkelstein SD, Barnes EL. (2003). Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol 27: 1559-1564
5. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE. (2003). BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88: 5399-5404
6. Xing M. (2005). BRAF mutation in thyroid cancer. Endocr Relat Cancer 12: 245-262
7. Han JM, Bae Kim W, Kim TY, Ryu JS, Gong G, Hong SJ, Kim JH, Oh YL, Jang HW, Kim SW, Chung JH, Shong YK. (2012). Time trend in tumour size and characteristics of anaplastic thyroid carcinoma. Clin Endocrinol (Oxf) 77: 459-464
8. Veness MJ, Porter GS, Morgan GJ. (2004). Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach. ANZ J Surg 74: 559-562
9. Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. (2005). Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 103: 1330-1335
10. Ibrahimpasic T, Ghossein R, Carlson DL, Chernichenko N, Nixon I, Palmer FL, Lee NY, Shaha AR, Patel SG, Tuttle RM, Balm AJ, Shah JP, Ganly I. (2013). Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience. Thyroid 23: 997-1002
11. Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J. (2007). Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31: 1256-1264
12. Kweon SS, Shin MH, Chung IJ, Kim YJ, Choi JS. (2013). Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea. Jpn J Clin Oncol 43: 1039-1046
13. Shin MH, Oh HK, Ahn YO. (2008). [Ten year trend of cancer incidence in Seoul, Korea: 1993-2002]. J Prev Med Public Health 41: 92-99
14. Shin HR, Jung KW, Won YJ, Kong HJ, Yim SH, Sung J, Seo SW, Kim KY, Lee SY, Kong IS, Hwang IK, Lee CW, Woo ZH, Lee TY, Choi JS, Yoo CI, Bae JM, Yoo KY. (2007). National cancer incidence for the year. (2002). in Korea. Cancer Res Treat 39: 139-149
15. Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, Lee EK, Kim KW, Yi KH, Chung JK, Youn YK, Cho NH, Park do J, Koh CS. (2013). Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid 23: 797-804
16. Choi JY, Hwang BH, Jung KC, Min HS, Koo do H, Youn YK, Lee KE. (2013). Clinical significance of microscopic anaplastic focus in papillary thyroid carcinoma. Surgery 154: 106-110
17. Ibrahimpasic T, Ghossein R, Carlson DL, Nixon I, Palmer FL, Shaha AR, Patel SG, Tuttle RM, Shah JP, Ganly I. (2014). Outcomes in patients with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab 99: 1245-1252
18. Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A. (2012). Poorly differentiated oncocytic thyroid carcinoma-diagnostic implications and outcome. Histopathology 60: 1045-1051
19. Orita Y, Sugitani I, Amemiya T, Fujimoto Y. (2011). Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma. Surgery 150: 1212-1219
20. Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ. (2002). The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 9: 57-64
21. Besic N, Hocevar M, Zgajnar J, Pogacnik A, Grazio-Frkovic S, Auersperg M. (2005). Prognostic factors in anaplastic carcinoma of the thyroid-A multivariate survival analysis of 188 patients. Langenbecks Arch Surg 390: 203-208
22. Voutilainen PE, Multanen M, Haapiainen RK, Leppaniemi AK, Sivula AH. (1999). Anaplastic thyroid carcinoma survival. World J Surg 23: 975-978; discussion 978-979
23. Passler C, Scheuba C, Prager G, Kaserer K, Flores JA, Vierhapper H, Niederle B. (1999). Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg 384: 284-293
24. Smallridge RC. (2012). Approach to the patient with anaplastic thyroid carcinoma. J Clin Endocrinol Metab 97: 2566-2572
25. Mohebati A, Dilorenzo M, Palmer F, Patel SG, Pfister D, Lee N, Tuttle RM, Shaha AR, Shah JP, Ganly I. (2014). Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol 21: 1665-1670
26. Conzo G, Polistena A, Calo PG, Bononi P, Gambardella C, Mauriello C, Tartaglia E, Avenia S, Sanguinetti A, Medas F, de Toma G, Avenia N. (2014). Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis. Int J Surg 12 Suppl 1: S178-182
27. Goutsouliak V, Hay JH. (2005). Anaplastic thyroid cancer in British Columbia 1985-1999: a population-based study. Clin Oncol 17: 75-78
28. Akaishi J, Sugino K, Kitagawa W, Nagahama M, Kameyama K, Shimizu K, Ito K, Ito K. (2011). Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid 21: 1183-1189
29. Polistena A, Monacelli M, Lucchini R, Triola R, Conti C, Avenia S, Rondelli F, Bugiantella W, Barillaro I, Sanguinetti A, Avenia N. (2014). The role of surgery in the treatment of thyroid anaplastic carcinoma in the elderly. Int J Surg Suppl 2: S170-176
30. Ito K, Hanamura T, Murayama K, Okada T, Watanabe T, Harada M, Ito T, Koyama H, Kanai T, Maeno K, Mochizuki Y, Amano J. (2012). Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors. Head Neck 34: 230-237
31. Brignardello E, Palestini N, Felicetti F, Castiglione A, Piovesan A, Gallo M, Freddi M, Ricardi U, Gasparri G, Ciccone G, Arvat E, Boccuzzi G. (2014). Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between. (1999). and 2012. Thyroid 24: 1600-1606
32. Sugitani I, Hasegawa Y, Sugasawa M, Tori M, Higashiyama T, Miyazaki M, Hosoi H, Orita Y, Kitano H. (2014). Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the anaplastic thyroid carcinoma research consortium of Japan database. Head Neck 36: 328-333
33. Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM; American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce. (2012). American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 22: 1104-1139
34. Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH. (2001). Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91: 2335-2342
35. Swaak-Kragten AT, de Wilt JH, Schmitz PI, Bontenbal M, Levendag PC. (2009). Multimodality treatment for anaplastic thyroid carcinoma-Treatment outcome in 75 patients. Radiother Oncol 92: 100-104
36. Junor EJ, Paul J, Reed NS. (1992). Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 18: 83-88
37. Busnardo B, Daniele O, Pelizzo MR, Mazzarotto R, Nacamulli D, Devido D, Mian C, GirelliME 2000Amultimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients. J Endocrinol Invest 23: 755-761
38. Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S. (2012). Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg 36: 1247-1254
39. Derbel O, Limem S, Segura-Ferlay C, Lifante JC, Carrie C, Peix JL, Borson-Chazot F, Bournaud C, Droz JP, de la Fouchardière C. (2011). Results of combined treatment of anaplastic thyroid carcinoma (ATC). BMC Cancer 11: 469
40. Sun C, Li Q, Hu Z, He J, Li C, Li G, Tao X, Yang A. (2013). Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China. PLoS One 8: e80011